相关实验视频

Updated: Sep 19, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

在Myasthenia Gravis中进行广泛的临床流动细胞计淋巴细胞表型:单中心研究

Hannes Lindahl^1,2, Malin Petersson², Sara Lind Enoksson^1,3

¹Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden.

Journal of neurochemistry

|June 17, 2025

概括

骨髓灰质炎患者的CD4 T细胞频率发生变化. 在未接受治疗的患者中,较高的CD4 T细胞计数表明,在一年内实现最小疾病的预后较差.

科学领域:

免疫学免疫学免疫学
神经学神经学
自免疫性疾病自免疫性疾病

背景情况:

骨髓灰质炎 (MG) 是一种自身免疫神经系统疾病,导致肌肉疲劳.
这种疾病涉及针对神经肌肉结接受体的自身抗体,但其致病性尚未完全理解.
识别预后生物标志物对于管理MG至关重要.

研究的目的:

在MG患者中表征外围血液淋巴细胞.
为了确定MG的疾病进展的预后生物标志物.
调查T和B细胞表型在MG结局中的作用.

主要方法:

对76例MG病例和健康对照的流细胞计数据的回顾性分析.
标准化的T细胞和B细胞面板用于分析细胞频率和表型.
来自瑞典MG注册的临床数据被用于结果分析,包括时间到最小的疾病表现.

主要成果:

未经治疗的MG患者与年龄相匹配的健康人群相比,CD4 T细胞的频率更高.
高CD4T细胞频率 (>75%的总T细胞) 与在一年内实现最小疾病的可能性降低有关.
在多变量分析中,CD4 T 细胞频率作为时间至疾病表现最小的独立风险因素出现.

结论:

患有MG的患者表现出改变的CD4 T细胞表型.
CD4 T细胞频率作为一个潜在的预后生物标志物用于肌痛性骨髓灰质炎的疾病进展.
对T细胞变化的进一步研究可能会阐明MG免疫病原发生.

关键词:

CD4 T 细胞是 CD4 的 T 细胞.流动细胞计量是流动细胞计量的方法.肌痛性骨髓灰质炎 (Myasthenia Gravis) 是一个严重的疾病.预测模型预测模型预后预后预后

更多相关视频

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper cTfh Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry

Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper cTfh Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry

Published on: January 7, 2019

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...